Resistance of leukemia cells to cytarabine chemotherapy is mediated by bone marrow stroma, involves cell-surface equilibrative nucleoside transporter-1 removal and correlates with patient outcome
Más información
| Título según WOS: | Resistance of leukemia cells to cytarabine chemotherapy is mediated by bone marrow stroma, involves cell-surface equilibrative nucleoside transporter-1 removal and correlates with patient outcome |
| Título según SCOPUS: | Resistance of leukemia cells to cytarabine chemotherapy is mediated by bone marrow stroma, involves cell-surface equilibrative nucleoside transporter-1 removal and correlates with patient outcome |
| Título de la Revista: | ONCOTARGET |
| Volumen: | 8 |
| Número: | 14 |
| Editorial: | IMPACT JOURNALS LLC |
| Fecha de publicación: | 2017 |
| Página de inicio: | 23073 |
| Página final: | 23086 |
| Idioma: | English |
| DOI: |
10.18632/oncotarget.14981 |
| Notas: | ISI, SCOPUS |